Irving Bryan 4
4 · FIVE PRIME THERAPEUTICS INC · Filed Feb 28, 2018
Insider Transaction Report
Form 4
Irving Bryan
SVP, Research
Transactions
- Award
Common Stock
2018-02-26+6,000→ 21,000 total - Award
Employee Stock Option (right to buy)
2018-02-26+35,000→ 35,000 totalExercise: $18.69Exp: 2028-02-25→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 26, 2019, 2020 and 2021, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through each such date.
- [F2]The shares underlying the option vest at a rate of one forty-eighth (1/48th) per month following February 26, 2018, provided the reporting person provides services the Company through each such date.